Diffusion capacity of the lung – a disease biomarker linking ventilation and circulation

Risk stratification of pulmonary arterial hypertension (PAH) is in the center of health care interests and has recently been addressed by numerous studies that are based on large international PH registries (1-5). Less evidence exists for Group 3 PH (6). Therefore, Rose et al, in their paper in this issue of JHLT, are to be commended on their efforts to identify predictors of survival in Group 3 PH patients, to characterize the clinical phenotypes and survival differences between patients with mild and severe Group 3 PH, and to evaluate how the etiology of lung disease impacts patient profiles and survival.

Source: The Journal of Heart and Lung Transplantation - December 1, 2018 Category: Transplant Surgery Authors: Inbal Shafran, Irene M Lang Tags: Editorial Source Type: research